Lebrikizumab-Lbkz
1 NDC across 1 manufacturer|0 Generic,1 Brand
Lebrikizumab-Lbkz is used to treat atopic dermatitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $3 million on Lebrikizumab-Lbkz across 292 claims for 168 beneficiaries.
Lebrikizumab-Lbkz is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $1783.52 to $1783.52 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$1783.52 – $1783.52
per ML
7d Activity
avg -0.1% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Eli Lilly and Company manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing LEBRIKIZUMAB-LBKZ
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
EBGLYSS 250 MG/2 ML PEN | $1783.5238 per ML | -0.05% |
Frequently Asked Questions
What is Lebrikizumab-Lbkz used to treat?
Lebrikizumab-Lbkz is used to treat atopic dermatitis, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Lebrikizumab-Lbkz?
In 2024, Medicare Part D spent $3 million on Lebrikizumab-Lbkz across 292 claims for 168 beneficiaries.
How many Lebrikizumab-Lbkz products are on the market?
The Lebrikizumab-Lbkz drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Lebrikizumab-Lbkz?
NADAC reference prices for Lebrikizumab-Lbkz range from $1783.5238 to $1783.5238 per ML.
Which manufacturers make Lebrikizumab-Lbkz?
1 manufacturer lists Lebrikizumab-Lbkz in NADAC. Ranked by number of NDCs, the largest are Eli Lilly and Company (1).
How has the price of Lebrikizumab-Lbkz changed recently?
Over the past 7 days, 0 Lebrikizumab-Lbkz NDCs rose and 1 fell, with a market-wide average change of -0.1%.